# When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing–remitting multiple sclerosis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/when-does-economic-model-type-become-a-decisive-factor-in-health-technology/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Kathleen Mary Noon,Stephen Montgomery,Nicholas Adlard,Michel Kroes |
| Citations | 7 |
| DOI | 10.1080/13696998.2018.1491007 |
| Fields | Economics, Econometrics and Finance,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.tandfonline.com/doi/pdf/10.1080/13696998.2018.1491007?needAccess=true&role=button |
| OpenAlex ID | https://openalex.org/W2809352624 |
| PMID | 29923439 |
| Type | article |
| Year | 2018 |

## Paper authors

- [Michel Kroes](https://scholariq.org/researchers/michel-kroes/)

## Paper journal

- [Journal of Medical Economics](https://scholariq.org/journals/journal-of-medical-economics/)

## Paper primary topic

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

## Paper topics

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.